+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2022-2026 Global Clinical Chemistry Analyzers and Reagents Market - Supplier Shares, Forecasts for 55 Tests, Opportunities in the US, Europe, Japan - Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline

  • PDF Icon

    Report

  • December 2021
  • Region: Europe, Global, Japan, United States
  • VPG Market Research
  • ID: 5509907
This report is a seven-country strategic analysis of major business opportunities emerging in the clinical chemistry market during the next five years. The report is available by section, and can be customized to specific information needs and budget. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

The report provides five-year volume and sales forecasts for over 55 clinical chemistry assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.

Rationale


The clinical chemistry market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Global Market Overview

  • Estimates of facilities performing clinical chemistry tests by country.
  • Test volume and sales projections by country.

Strategic Recommendations

  • New product development opportunities with significant market appeal.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.

Competitive Assessments


Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
  • The companies analyzed in the report include Abbott Laboratories, Agilent Technologies, Beckman Coulter/Danaher, bioMerieux, Bio-Rad, DiaSorin, Eiken Chemical, Fujirebio, Grifols, Instrumentation Laboratory/Werfen, Kyowa Medex, Ortho-Clinical Diagnostics, PerkinElmer, Quest Diagnostics, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Tosoh, Wako.

Individual Tests Analyzed in the Report

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), Calcitonin, Calcium, Carbon Dioxide/Bicarbonate, Cardio hs CRP, Chloride, Cholesterol, Cholinesterase, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Cystatin C, Ferritin, Fructosamine, GGT, Glucose, HDL Cholesterol, Homocysteine, hs-CRP, Insulin, Iron, Iron (Total Binding Capacity), Iron (Unsaturated Binding Capacity), LDH, LDL Cholesterol, LDL Cholesterol Direct, Lipase, Lipoprotein a, Magnesium, Microalbumin, Myoglobin, NT-proBNP, Phosphorus, Potassium, Sodium, ST2, Total Protein, Transferrin, Triglycerides, Troponin, Uric Acid

Geographic Coverage


France, Germany, Italy, Japan, Spain, UK, US

Market Segmentation Analysis

  • Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.
  • Test volume and sales forecasts for over 55 clinical chemistry assays, by country and market segment (Hospitals, Commercial/Private Laboratories, Physician Offices/Group Practices, and Ambulatory Care Centers).

Current and Emerging Products

  • Analysis of current and emerging clinical chemistry tests.
  • Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.

Technology Review

  • Assessment of current and emerging
  • Comprehensive lists of companies developing or marketing new technologies and products by test.

Companies Profiled

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • bioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken Chemical
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory/Werfen
  • Kyowa Medex
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • Quest Diagnostics
  • Roche
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako